Trials / Sponsors / Opthea Limited
Opthea Limited
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD) Neovascular Age-related Macular Degeneration | Phase 3 | 2021-03-12 |
| Terminated | OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD) Neovascular Age-related Macular Degeneration | Phase 3 | 2021-03-12 |
| Completed | A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema Diabetic Macular Edema | Phase 1 / Phase 2 | 2018-01-16 |
| Completed | A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD Neovascular Age-related Macular Degeneration | Phase 2 | 2017-11-06 |
| Completed | Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Pat Eye Diseases, Macular Degeneration, Retinal Diseases | Phase 1 | 2015-07-01 |